Dermocosmetic Treatment for Facial Redness in Rosacea With or Without Laser Therapy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorISISPHARMA
About this trial
The aim of this clinical study is to evaluate the effectiveness and safety of a dermocosmetic product in reducing facial redness and visible blood vessels associated with erythematotelangiectatic rosacea.
Investigators will compare the dermocosmetic product to a placebo applied to opposite sides of the face, when used alone and in combination with laser treatment.
Participants will apply the products twice daily for 2 month followed by continued use in combination with laser treatment, and will attend regular clinical visits for assessments and questionnaires.
Eligibility criteria
Qualifiers
Gender: male or female
Age: > 18 years -Patients with mild to severe erythro-couperotic rosacea (stage 2, 3, or 4 - TRoSA scale, section 2.2.3.1)
Patients wishing to undergo vascular laser treatments for their rosacea
Patients who have provided informed consent
Disqualifiers
Pregnant patients or patients with a positive urine pregnancy test at the initial visit
Patients with another condition in the study area.
Patients who have received laser treatment for the same condition within the previous 12 months.
Patients with another form of rosacea (e.g., papules and pustules, ocular rosacea, etc.).
Trial design
Treatments tested in this trial
- Dermocosmetic tested product
- Placebo
- Vascular laser treatment
Treatment groups
50 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov